Patent in Medical News

Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent Litigation

DETROIT, Aug. 3 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) announces today that it has executed a settlement agreement with MedImmune, stipulating the dismissal of the lawsuits filed in the United States District Court for the District of Maryland r...

Canada Grants PLC Systems First Patent for RenalGuard(R)

FRANKLIN, Mass., July 27 /PRNewswire-FirstCall/ -- PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced it has been issued a patent for the real-time fluid balancing capabilities provided by ...

Abbott and Medtronic Reach Agreement on Global Patent Disputes

ABBOTT PARK, Ill., July 27 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT ) announced today a settlement resolving all outstanding intellectual property litigation between the two parties. Under the terms of the settlement, Medtronic will pay Abbott $400 million. The settlement al...

United States Patent Office Issues Decision in Re-examination Proceedings

ST. PETERSBURG, Fla. , July 24 /PRNewswire-FirstCall/ -- Smith & Nephew Inc.'s Advanced Wound Management division (LSE: SN; NYSE: SNN ) announced that the United States Patent and Trademark Office (Patent Office) has issued actions in re-examination proceedings involving thr...

Align Technology Provides Update on Patent Litigation with Ormco Corporation

SANTA CLARA, Calif., July 21 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN ) today provided an update on the a lawsuit brought by Ormco Corporation (Ormco) against Align Technology, Inc. (Align) in the U.S. District Court for the Central District of California (Distric...

PARI Granted US Patent for Vortex Holding Chamber

MIDLOTHIAN, Va., July 21 /PRNewswire/ -- Today, PARI Respiratory Equipment was granted a US Patent for its Vortex Holding Chamber, a unique, non-electrostatic, holding chamber with a one piece, dual-valve system that optimizes patient inhalation and exhalation for more efficient medicati...

Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.

PORTON DOWN, England, July 16 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed two patent license agreements with Roche Molecular Systems, Inc. (RMS). The licenses signed on 15 July 2009,...

Medizone International, Inc. Has Filed for Patent Protection for Its AsepticSure(TM) Hospital Sterilization System

SAN FRANCISCO, July 13 /PRNewswire-FirstCall/ -- Following months of engineering development and laboratory research Medizone (MZEI.PK) has filed what it believes to be a very solid patent application for the Company's lead product AsepticSure(TM). Medizone's CEO Edwin Marshall stated, ...

Uroplasty Announces Patent Issuance Related to the Urgent(R) PC System

MINNEAPOLIS, July 13 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,536,226 entitle...

Millipore Sues W.L. Gore & Associates for Patent Infringement

BILLERICA, Mass., July 10 /PRNewswire/ -- Millipore Corporation , a leading provider of technologies, tools and services for the global life science industry, including bioscience research and biopharmaceutical manufacturing , has filed a lawsuit in the United States District Court for the D...

Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO(R) Patent Litigation

NEW YORK, July 10, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX ) and its wholly-owned subsidiary, Forest Laboratories Holdings, Ltd. (collectively, "Forest"), and H. Lundbeck A/S ("Lundbeck") announced today that they have entered into a settlement agreement with Sun Pha...

Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation

DETROIT, July 10 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) announced that, as part of the settlement of the legal proceedings related to Lexapro(R) (escitalopram oxalate) tablets, it entered into an Asset Purchase Agreement with Forest Laboratories, Inc...

Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community

AstraZeneca Patent Shown to be Invalid Based on New Prior Art; JSA Technologies Patent Study Yields Strong Invalidity Evidence NEW YORK, July 1 /PRNewswire/ -- Article One Partners, LLC has discovered new prior art impacting the validity of AstraZeneca's Crestor U.S. drug patent, in closing ...

Align Technology Announces Jury Verdict in Patent Litigation With Ormco Corporation

SANTA CLARA, Calif., June 26 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN ) today announced that a jury delivered a verdict against Align in a lawsuit brought by Ormco Corporation (Ormco) against Align Technology, Inc. (Align) in the U.S. District Court for the Central District...

RainEarth Obtains Patent Approvals for Its Core Technology

BEIJING, June 26 /PRNewswire-Asia/ -- RainEarth Inc. (OTC Bulletin Board: RNER; "the Company"), announced that its contractual partner in China, Beijing RainEarth Technology Co. Ltd., ("China RainEarth"), has obtained patent approvals for its core technology, which consists of products that ai...

Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform

-- New Claims Cover Use of Phosphatidylserine-Targeting Antibodies to Image Solid Tumors and Other Malignancies -- -- Supported by Published Data Showing Utility of PS-Targeting Antibodies for the Molecular Imaging of Cancer -- TUSTIN, Calif., June 24 /PRNewswire-FirstCall/ -- Pereg...

U.S. Patent Infringement Lawsuit Filed by Aperio Technologies, Inc.

HAMAMATSU, Japan, June 23 /PRNewswire/ -- A U.S. patent infringement lawsuit was filed on June 10, 2009, against Hamamatsu Photonics K.K., Hamamatsu Corporation, and Olympus America, Inc. The lawsuit, brought by Aperio Technologies, Inc. in the U.S. District Court for the District of Delaware, ac...

Enigma Diagnostics Announces Patent On Real-Time Monitoring of Amplification Reactions Upheld In Entirety Following Opposition From BD at European Patent Office

PORTON DOWN, England, June 16 /PRNewswire/ -- Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today it was issued European Patent EP1044283, which covers the use of endonuclease-based reporting in PCR and other nucleic acid amplification tec...

Palomar Successful in U.S. Patent Office Re-Examination of Hair Removal Patent

Palomar to Seek Re-Start of Patent Infringement Lawsuit Against Candela BURLINGTON, Mass., June 15 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI ), a leading researcher and developer of light-based systems for cosmetic treatments, announced today that the U.S. ...

Impliant Granted Two New U.S. Patents and Successfully Defends European Patent Opposition Case

PRINCETON, N.J., June 9 /PRNewswire/ -- Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that the European Patent Office has confirmed the validity of one of its key patents following an Opposition by Archus Orthopedics, Inc. (Redmond, WA) tha...

RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment

BEIJING, June 9 /PRNewswire-Asia/ -- RainEarth Inc. (OTC Bulletin Board: RNER; "the Company"), announced today that its contractual partner in China, Beijing RainEarth Technology Co. Ltd., ("China RainEarth"), has submitted a patent application for its second generation of blood dialysis. ...

Fenwal Statement Regarding Patent Litigation

Company plans appeal and uninterrupted supply for customers LAKE ZURICH, Ill., June 4 /PRNewswire/ -- Fenwal Inc., a global leader focused on improving blood collection, safety and availability for patient care, said it will appeal the decision by a Boston court in a patent lawsuit brought by...

United States Patent and Trademark Office Accepts CoolTouch's Re-examination Request for Cynosure '873 Patent

On May 22, 2009 the United States Patent & Trademark Office (USPTO) accepted CoolTouch's request to re-examine the '873 Paolini laser lipolysis patent based on prior art by Dr. David Apfelberg and Mr. David Hennings. Roseville, CA (PRWEB) June 2, 2009 -- On May 22,...

Mylan's Chief Operating Officer Heather Bresch to Testify Before Congress Concerning Patent Settlements Between Brand and Generic Pharmaceutical Companies and Tactics That Delay Market Entry of High Quality, Affordable Generic Drugs

PITTSBURGH, June 1 /PRNewswire-FirstCall/ -- WHAT: Mylan Inc. (Nasdaq: MYL ) has accepted an invitation to testify before the U.S. House of Representatives Judiciary Subcommittee on Courts and Competition Policy at its upcoming hearing: "Pay to Delay: Are Patent Settlements That Delay Ge...

Niutang Sucralose Patent Litigation Successfully Concluded

Tate & Lyle will not appeal ITC decision; Voluntarily dismisses District Court case BREA, Calif., June 1 /PRNewswire/ -- Changzhou Niutang , one of the largest global manufacturers of sucralose , and its U.S. subsidiary, US Niutang, today announced that Tate & Lyle will not appe...

Falcon Genomics Awarded Patent for Innovative Cancer Test

Patent Covers High-throughput, Anchorage-independent Assay for Screening Compounds for Inhibition of Cancer Cell Growth. PITTSBURGH, May 28 /PRNewswire/ -- Falcon Genomics, Inc. announced today that it has received U.S. Patent # 7,537,913 with claims covering the Company's Cancer BioChip Syst...

Viral Genetics Has Option Under Issued Key Patent for Cancer Drug

SAN MARINO, Calif., May 21 /PRNewswire-FirstCall/ -- Biotechnology firm Viral Genetics, Inc. (Pink Sheets: VRAL), a company that discovers and develops drug compounds to treat cancer, Lyme Disease and HIV, has been issued a patent for novel cancer therapies. The patent protects cancer drugs that h...

CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS)

LAS VEGAS, May 21 /PRNewswire-FirstCall/ -- CPC of America, Inc. (OTC Bulletin Board: CPCF.OB), announced today the filing of its first patent of a synthetic sealant for specific application to the MedClose(TM) VCS. CPC is focused on the development and testing of the MedClose(TM) VCS, which is a...

Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation

WILMINGTON, Del., May 20 /PRNewswire-FirstCall/ -- On May 20, 2009, the US District Court for the District of New Jersey granted the request of AstraZeneca (NYSE: AZN ) for an injunction barring Apotex (Apotex, Inc. and Apotex Corp.) from launching a generic version of AstraZeneca's PULMICORT ...

Appeal Proceedings on European VisionBlue Patent Stayed; Patent Remains in Force

ZUIDLAND, The Netherlands, May 20 /PRNewswire/ -- The Technical Board of Appeal of the European Patent Office has postponed its final decision on two appeals lodged by two competitors against an earlier decision to maintain the European patent for VisionBlue. (Photo: http://www.newscom...

Intradigm Announces Issuance of RNA Interference (RNAi) Patent Covering Potent siRNA Sequence

First Patent to be Issued from Among Intradigm's Large Collection of Pending siRNA Sequence Patents PALO ALTO, Calif., May 19 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced the issuance of United States pa...

Palomar Wins Two European Hair Removal Patent Opposition Hearings

BURLINGTON, Mass., May 14 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI ), a leading researcher and developer of light-based systems for cosmetic treatments, announced today that Palomar won two patent opposition cases held at the European Patent Office on May 6 and ...

Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel

CINCINNATI, May 13, 2009 /PRNewswire/ -- Today, the United States Court of Appeals for the Federal Circuit ruled in favor of The Procter & Gamble Company (P&G) in the patent infringement lawsuit filed by P&G against Teva Pharmaceuticals USA, Inc. The positive ruling protects P&G's...

NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey

NEW YORK, May 6 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, has filed a patent application claiming the proprietary stem cell technology of Vincent C. Gia...

Gene Network Sciences Awarded Patent Covering REFS(TM) Platform

CAMBRIDGE, Mass., May 4 /PRNewswire/ -- Gene Network Sciences, Inc. (GNS) today announced that it has been awarded U.S. Patent No. 7,512,497, entitled "Systems and Methods for Inferring Biological Networks." The patent covers GNS's core model learning and simulation platform, REFS(TM) (Reverse Eng...

Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics

- Court Orders Confiscation of Diagnostica Stago's Inventory of Infringing Products - BEDFORD, Mass., May 4 /PRNewswire/ -- Instrumentation Laboratory Company and its parent company Instrumentation Laboratory S.p.A. (IL) today announced that the Paris First Level Civil Court determined th...

Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies

MENLO PARK, Calif., May 4 /PRNewswire/ -- Acclarent, Inc., the pioneer of Balloon Sinuplasty (TM) technologies for use in the treatment of chronic sinusitis, announced today that the U.S. Patent and Trademark Office awarded U.S. Patent Number 7,500,971, entitled "Devices, Systems and Methods for ...

Smith & Nephew Encouraged by United Kingdom NPWT Patent Court Decision

HULL, England, May 1 /PRNewswire-FirstCall/ -- Smith & Nephew's Advanced Wound Management business (LSE: SN; NYSE: SNN ) announces that the Patents Court, in the High Court of Justice of England and Wales, has ruled as invalid 7 out of the 10 claims asserted against Smith & Nephew of the...

The Quantum Group Announces Filing of Utility Patent Application

WELLINGTON, Fla., April 28 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (NYSE Amex: QGP ) announced today that it has filed a utility patent application to enhance the security architecture of PWeR(TM), (Personal Wellness electronic Record), the Quantum healthcare technolo...

Par Pharmaceutical Enters Into Agreement With Reliant Pharmaceuticals to Settle Patent Litigation Over Rythmol(R) SR

WOODCLIFF LAKE, N.J., April 21 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX ) ("Par") today announced it has entered into a settlement agreement with Reliant Pharmaceuticals, Inc. ("Reliant") that resolves patent litigation related to Reliant's Rythmol (R) SR produc...